Anybody who knows the track history of Prana should understand the antibiotic properties of PBT series compounds. That could be one of the reasons why FDA is particularly strict with PBT2's safety issues. Rudy doesn't say anything new this time. He is more cautious about his sayings, e.g., he would say "Our new study" not "GROUNDBREAKING new work by Rudy Tanzi". One thing interesting is why PBT2 was not tested in this work. Maybe PBT2 will appear on a higher level journal soon.
Anybody who knows the track history of Prana should understand...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $4.734K | 1.341M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 49 | 30295639 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 129917446 | 34 |
View Market Depth
| Last trade - 15.44pm 15/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |